ominous
发表于 2025-3-21 18:17:45
书目名称Kooperativer Führungsstil und Organisation影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0545848<br><br> <br><br>书目名称Kooperativer Führungsstil und Organisation影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0545848<br><br> <br><br>书目名称Kooperativer Führungsstil und Organisation网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0545848<br><br> <br><br>书目名称Kooperativer Führungsstil und Organisation网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0545848<br><br> <br><br>书目名称Kooperativer Führungsstil und Organisation被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0545848<br><br> <br><br>书目名称Kooperativer Führungsstil und Organisation被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0545848<br><br> <br><br>书目名称Kooperativer Führungsstil und Organisation年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0545848<br><br> <br><br>书目名称Kooperativer Führungsstil und Organisation年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0545848<br><br> <br><br>书目名称Kooperativer Führungsstil und Organisation读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0545848<br><br> <br><br>书目名称Kooperativer Führungsstil und Organisation读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0545848<br><br> <br><br>
连锁,连串
发表于 2025-3-21 22:01:17
http://reply.papertrans.cn/55/5459/545848/545848_2.png
outset
发表于 2025-3-22 04:04:08
Günter Zepfed for the treatment of genotype 1 HCV infection. The research and development team at Abbott/AbbVie based their approach to HCV cure on the use of three DAAs to avoid emergence of resistance, anchored by a potent protease inhibitor and NS5A inhibitor. Clinical trials were designed to answer multipl
Fillet,Filet
发表于 2025-3-22 04:53:58
http://reply.papertrans.cn/55/5459/545848/545848_4.png
institute
发表于 2025-3-22 09:58:32
http://reply.papertrans.cn/55/5459/545848/545848_5.png
AFFIX
发表于 2025-3-22 15:31:03
Günter Zepfipasvir and the nonstructural 5B protein (NS5B) nucleotide inhibitor sofosbuvir (SOF), provided a major advancement in the treatment of individuals with chronic genotype 1 (GT1) HCV infection. Herein is described the discovery of velpatasvir (VEL, GS-5816), a pan-genotypic NS5A inhibitor with low pi
偏离
发表于 2025-3-22 19:34:22
Günter Zepfe advanced liver disease. This has resulted in a reduced incidence of liver cancers and reduced liver-related mortality. Benefits of cure in patients without cirrhosis have not been seen yet in systemic review, but are likely to be seen in the future years. There remain unresolved issues regarding p
外貌
发表于 2025-3-23 00:16:05
http://reply.papertrans.cn/55/5459/545848/545848_8.png
指数
发表于 2025-3-23 04:13:41
Günter Zepft to understand basic HCV biology, which led to the development of HCV cell culture systems eventually enabling drug discovery. Initial studies focused on biochemical characterization of viral proteins and dissected their roles in the virus life cycle. Two of the viral proteins, NS3-4A protease and
Vulnerable
发表于 2025-3-23 09:19:57
http://reply.papertrans.cn/55/5459/545848/545848_10.png